National UV Safety Month

National UV Safety Month July means fun in the sun for many people. But with the bright and sunny weather comes higher exposure to harmful Ultraviolet (UV) rays, which are the main cause of skin cells turning into cancer. Taking extra precautions with your skin this summer is more important than ever, as the rate of skin cancer has increased dramatically over the last decade. According to the American Cancer Society, skin cancer is the most common cancer in the United States. More skin cancers are diagnosed each year than all other cancers combined.
Read more

In Honor of Lynn Waltz — A True Hero of the Myasthenia Gravis Community

It is with great sadness that the InfuCare Rx team announces the loss of a dear friend and patient, Lenora “Lynn” Waltz. We have been honored with the privilege of knowing and treating Lynn for more than fifteen years. Lynn was instrumental in starting a local Myasthenia Gravis (MG) support group near Pasadena, Maryland, which ultimately became the Myasthenia Gravis Foundation of America (MGFA). Lynn was a passionate, fearless, and tremendous advocate who was a source of strength for many newly diagnosed MG patients.
Read more

InfuCare Rx Selected as a Preferred Provider by Cigna’s eviCore healthcare for Specialty and Non-Specialty Infusion Services

ASTON, Pennsylvania, February 10, 2021 – InfuCare Rx, a leading nationwide specialty infusion provider in the treatment of acute and chronic conditions, announced this week their selection as a preferred provider in Cigna’s eviCore healthcare specialty pharmacy network. InfuCare Rx has been selected as a preferred provider based on its high quality clinical therapy management capabilities, national scope and real-time data driven outcomes reporting through its proprietary digital solution, InfuCare Rx Health. InfuCare Rx will provide a variety of specialty and non-specialty infusion services to Cigna members through eviCore healthcare. These services will include anti-infective therapy, bleeding disorders, immunoglobulin therapy (IV and subcutaneous), parenteral nutrition and specialty biologics effective February 1, 2021.
Read more